Velaf 37.5mg Tablet ER
By Velaf
Rx
10 Tablet ER in a Strip

Composition
Venlafaxine(37.5mg)

Manufacturer - Crescent Therapeutics Ltd
SCO-58, 59, Sector-17D Chandigarh-160017

Expires on or after
October, 2025

liver
When using Velaf 37.5mg Tablet ER, caution is advised for patients with liver disease. It may be necessary to adjust the dosage of Velaf 37.5mg Tablet ER in such cases. It is important to consult your doctor before taking this medication if you have liver issues.

kidney
Velaf 37.5mg Tablet ER requires caution in patients with kidney disease. Adjustments in dosage may be necessary. Consult your doctor for proper guidance.

alcohol
It is not safe to drink alcohol while taking Velaf 37.5mg Tablet ER.

driving
When taking Velaf 37.5mg Tablet ER, be aware that it can cause dizziness, confusion, and blurred vision which may impact your driving ability.

pregnancy
Velaf 37.5mg Tablet ER should be avoided during pregnancy as it may not be safe. Studies on animals have indicated potential harm to the developing baby. It's important to discuss with your doctor the potential risks and benefits before taking this medication.

breastfeeding
Velaf 37.5mg Tablet ER should be avoided during breastfeeding as it may pass into breastmilk, potentially harming the baby. Watch for signs like excessive sleepiness and monitor baby's weight gain closely.
Habit Forming | No |
Chemical Class | Anisole Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹29
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024